X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs MERCK LTD - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD MERCK LTD STRIDES SHASUN LTD/
MERCK LTD
 
P/E (TTM) x 14.1 26.1 54.1% View Chart
P/BV x 1.9 2.9 65.4% View Chart
Dividend Yield % 0.5 1.0 56.3%  

Financials

 STRIDES SHASUN LTD   MERCK LTD
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-16
MERCK LTD
Dec-16
STRIDES SHASUN LTD/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1,4131,060 133.3%   
Low Rs848623 136.1%   
Sales per share (Unadj.) Rs353.3632.4 55.9%  
Earnings per share (Unadj.) Rs23.445.7 51.2%  
Cash flow per share (Unadj.) Rs41.062.3 65.8%  
Dividends per share (Unadj.) Rs5.0011.00 45.5%  
Dividend yield (eoy) %0.41.3 33.8%  
Book value per share (Unadj.) Rs320.4388.8 82.4%  
Shares outstanding (eoy) m89.3516.60 538.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x3.21.3 240.5%   
Avg P/E ratio x48.318.4 262.6%  
P/CF ratio (eoy) x27.613.5 204.2%  
Price / Book Value ratio x3.52.2 163.0%  
Dividend payout %21.424.1 88.9%   
Avg Mkt Cap Rs m100,98813,969 722.9%   
No. of employees `0004.71.6 296.3%   
Total wages/salary Rs m4,9881,487 335.5%   
Avg. sales/employee Rs Th6,730.06,631.9 101.5%   
Avg. wages/employee Rs Th1,063.6939.2 113.3%   
Avg. net profit/employee Rs Th445.5479.4 92.9%   
INCOME DATA
Net Sales Rs m31,56410,498 300.7%  
Other income Rs m1,212242 500.1%   
Total revenues Rs m32,77610,741 305.2%   
Gross profit Rs m5,2131,135 459.2%  
Depreciation Rs m1,573276 570.9%   
Interest Rs m1,8030-   
Profit before tax Rs m3,0491,102 276.6%   
Minority Interest Rs m1270-   
Prior Period Items Rs m-270-   
Extraordinary Inc (Exp) Rs m-3710-   
Tax Rs m689343 200.6%   
Profit after tax Rs m2,089759 275.3%  
Gross profit margin %16.510.8 152.7%  
Effective tax rate %22.631.1 72.5%   
Net profit margin %6.67.2 91.6%  
BALANCE SHEET DATA
Current assets Rs m35,9496,410 560.9%   
Current liabilities Rs m19,4028,828 219.8%   
Net working cap to sales %52.4-23.0 -227.5%  
Current ratio x1.90.7 255.2%  
Inventory Days Days7158 122.9%  
Debtors Days Days12738 330.3%  
Net fixed assets Rs m34,4781,406 2,451.5%   
Share capital Rs m894166 538.3%   
"Free" reserves Rs m22,6016,286 359.5%   
Net worth Rs m28,6326,455 443.6%   
Long term debt Rs m27,4550-   
Total assets Rs m76,5918,828 867.6%  
Interest coverage x2.7NM-  
Debt to equity ratio x1.00-  
Sales to assets ratio x0.41.2 34.7%   
Return on assets %5.18.6 59.1%  
Return on equity %7.311.8 62.1%  
Return on capital %8.217.1 47.8%  
Exports to sales %48.18.3 581.2%   
Imports to sales %14.521.0 68.7%   
Exports (fob) Rs m15,192869 1,747.4%   
Imports (cif) Rs m4,5652,209 206.6%   
Fx inflow Rs m16,612959 1,732.6%   
Fx outflow Rs m5,2922,612 202.6%   
Net fx Rs m11,320-1,653 -684.7%   
CASH FLOW
From Operations Rs m7171,070 66.9%  
From Investments Rs m-22,284-750 2,972.4%  
From Financial Activity Rs m29,488-150 -19,684.6%  
Net Cashflow Rs m8,073171 4,723.8%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 37.8 18.2 207.7%  
FIIs % 8.6 1.0 860.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 29.1 89.0%  
Shareholders   56,241 28,591 196.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   SHASUN PHARMA  CIPLA  ABBOTT INDIA  UNICHEM LAB  WYETH LTD  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bank Stocks Witness Selling(01:30 pm)

After opening the day on a flat note, the Indian share markets have reversed the trend and are currently trading above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 17, 2017 03:37 PM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS